J&J and Pfizer quietly resolve Remicade biosimilar lawsuit

This is interesting. J&J and Pfizer quietly had resolved an Remicade biosimilar lawsuit which most of MSM outlets arent even reporting on this interesting news story as this one article pointed out.

Pfizer undertook took anticompetitive practices in a bid to protect Remicade. I dont have much to add as my own thoughts on the matter. But this is interesting.

J&J and Pfizer quietly resolve Remicade biosimilar lawsuit

As a result – Pfizer alleged – this restricted use of Pfizer's infliximab biosimilar Inflectra, which it originally launched in 2016. Among the anticompetitive practices that Pfizer accused J&J of was contracting with payers and providers to prevent use of Inflectra, with Remicade payer contracts allegedly written to deny reimbursement for Inflectra, apart from cases where J&J’s drug had proven ineffective for patients.

a reply to: HawkEyi


Wow the medication is for treating a lot of illnesses, but does it works? it seems that is not soo clear, but I guess is competition at its finest.